Journal article icon

Journal article

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients

Abstract:
Despite many shortcomings, liver biopsy is regarded as the gold standard for assessing liver fibrosis. A less invasive and equally or more reliable approach would constitute a major advancement in the field. Proteomics can aid discovery of novel serological markers and these proteins can be measured in patient blood. A major challenge of discovering biomarkers in serum is the presence of highly abundant serum proteins, which restricts the levels of total protein loaded onto gels and limits the detection of low abundance features. To overcome this problem, we used two-dimensional gel eletrophoresis (2-DE) over a narrow pH 3-5.6 range since this lies outside the range of highly abundant albumin, transferrin and immunoglobulins. In addition, we used in-solution isoelectric focusing followed by SDS-PAGE to find biomarkers in hepatitis C induced liver cirrhosis. Using the pH 3-5.6 range for 2-DE, we achieved improved representation of low abundance features and enhanced separation. We found in-solution isoelectric focusing to be beneficial for analyzing basic, high molecular weight proteins. Using this method, the beta chains of both complement C3 and C4 were found to decrease in serum from hepatitis C patients with cirrhosis, a change not observed previously by 2-DE. We present two proteomics approaches that can aid in the discovery of clinical biomarkers in various diseases and discuss how these approaches have helped to identify 23 novel biomarkers for hepatic fibrosis.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1021/pr101077c

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Biochemistry
Research group:
Oxford Antiviral Drug Discovery Unit, Oxford Glycobiology Institute
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Biochemistry
Research group:
Oxford Antiviral Drug Discovery Unit, Oxford Glycobiology Institute
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Biochemistry
Research group:
Oxford Antiviral Drug Discovery Unit, Oxford Glycobiology Institute
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Biochemistry
Research group:
Oxford Antiviral Drug Discovery Unit, Oxford Glycobiology Institute
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Biochemistry
Research group:
Oxford Antiviral Drug Discovery Unit, Oxford Glycobiology Institute
Role:
Author


Publisher:
American Chemical Society
Journal:
Journal of Proteome Research More from this journal
Volume:
10
Issue:
5
Pages:
2643-2650
Publication date:
2011-01-01
Edition:
Publisher's version
DOI:
EISSN:
1535-3907
ISSN:
1535-3893


Language:
English
Keywords:
Subjects:
UUID:
uuid:039a9a3e-64cc-4533-9a51-ce3a50d731d3
Local pid:
ora:5973
Deposit date:
2011-12-19
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP